Bristol-Myers Positive, Cooper Jumps, WBD Declines

Bristol-Myers (BMY) received a boost as analysts cited positive readthrough from Bayer’s promising stroke‑prevention data, supporting confidence in BMY’s secondary stroke program after earlier pipeline setbacks. Cooper (COO) jumped after activist investor Browning West — reported to own about 4% — sent a letter calling the board’s oversight “inadequate,” urging board changes, a pause to any restructuring and proposing its director slate to refocus the company after missed guidance. Warner Bros. Discovery (WBD) drew takeover interest with Netflix, Comcast, Paramount and Skydance submitting first bids by the Nov. 20 deadline (Comcast/Netflix focused on the film/TV library; Paramount willing to buy the whole company), but WBD may not reach a deal and could proceed with plans to separate its cable networks next year.

Analysis

Market structure: Activism at COO raises near‑term takeover/reorg optionality that benefits event‑driven managers and brokers while pressuring incumbent management and lenders; Comcast (CMCSA) faces optionality cost if it bids aggressively for WBD content, tightening its near‑term free cash flow by an estimated $2–5bn if a library purchase occurs. WBD’s auction creates asymmetric upside for equity holders (binary takeover or break‑up value) and raises implied credit spreads for its bonds by ~50–150bps until resolution; streaming rivals face incremental scarcity of legacy film/TV rights, which supports pricing for catalogs.

Risk assessment: Tail risks include failed financing/anticompetitive block on a WBD buyer (high impact, 10–30% equity downside), a contested COO proxy fight that prolongs governance uncertainty >6 months, or a BMY pipeline readout that disappoints (binary clinical tail). Immediate effects (days): implied vols and credit spreads spike; short‑term (weeks–months): proxy deadlines, bid signaling and separation plans resolve; long‑term (quarters): realized earnings and pipeline outcomes reprice fundamentals. Hidden dependency: WBD breakup value depends on tax/agency carve‑out mechanics and affiliate distribution contracts that can nullify expected synergies.

Trade implications: Favor small, convex positions: asymmetric long WBD exposure to capture takeover premium while limiting downside via call spreads; modest long BMY exposure to capture readthrough with size capped at 2–3% until pivotal data within 3–12 months. For COO, staged accumulation tied to governance milestones (board resignations or formal proxy filing within 60 days); use LEAPS calls to limit downside. Rotate out of lower‑quality legacy media equity into diversified content/catalog ETFs and selectively into IG credit if M&A financing drives spread tightening.

Contrarian angles: Consensus underestimates structural value unlocked by a tax‑efficient WBD split — if executed, combined market caps could rerate by 20–40% over 12–24 months; conversely consensus may be overly sanguine on potential suitors’ willingness to pay, making short gamma expensive. Historical parallels: Discovery/AT&T style breakups show initial knee‑jerk volatility then multi‑quarter alpha if execution clarity emerges. Unintended consequence: aggressive bidding could force Comcast to deleverage, compressing its dividend capacity and creating a 10–15% downside risk to CMCSA equity absent clear synergies.

Key Decisions for Investors

• Establish a 2–3% long position in BMY within 10 trading days to capture pipeline readthrough; set a 12% stop‑loss and target +25–35% over 12–18 months if follow‑on pivotal trials are green‑lit.
• Deploy a 0.5–1.0% NAV WBD event‑driven position via Jan 2026 call spreads (buy 25–30% OTM, sell 60% OTM) to cap downside; scale up to 2% if a credible lead bidder emerges within 30 days or price rises >20%; exit on definitive deal or by 01/31/2026.
• Initiate a staged 1–2% long in COO conditioned on formal proxy filing or board changes within 60 days: tranche 40% on filing, 60% on a public board concession; hedge with 6–9 month OTM puts sized to cap drawdown at 8% NAV.
• Short 1% of CMCSA equity (or buy 1–2% notional put spread 3–6 month expiry) if Comcast announces >$3bn discretionary content purchases or net leverage increases >0.3x from current levels; target 8–12% downside and tighten if dividend policy is cut.